Efficacy and safety of obinutuzumab in active lupus nephritis
Clinical Kidney Journal · 02.07.2025 · 18 (7)
DOI: 10.1093/ckj/sfaf161 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Kidney Journal, online erschienen am 26.06.2025. Verfasst von Corina-Daniela Ene und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Internal Medicine, Faculty of General Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Ene Corina-Daniela, Bruchfeld Annette; HEfficacy and Safety of Obinutuzumab in Active Lupus Nephritis, Clinical Kidney Journal, , sfaf161, https://doi.org/
Autor:innen und Institutionen
- Department of Nephrology and Internal Medicine, Faculty of General Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
- Dr Carol Davila Clinical Hospital of Nephrology, Bucharest, Romania.
- Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Stockholm, Sweden.
- Department of Renal Medicine, Karolinska University Hospital and CLINTEC Karolinska Institutet, Stockholm, Sweden.
ORCID-Profile: Corina-Daniela Ene, Annette Bruchfeld
Zitieren
APA
Ene, C. D., & Bruchfeld, A. (2025). Efficacy and safety of obinutuzumab in active lupus nephritis. Clinical Kidney Journal, 18(7). https://doi.org/10.1093/ckj/sfaf161
Vancouver
Ene CD, Bruchfeld A. Efficacy and safety of obinutuzumab in active lupus nephritis. Clinical Kidney Journal. 2025;18(7). doi:10.1093/ckj/sfaf161
BibTeX
@article{Ene2025,
author = {Ene, Corina-Daniela and Bruchfeld, Annette},
title = {Efficacy and safety of obinutuzumab in active lupus nephritis},
journal = {Clinical Kidney Journal},
year = {2025},
volume = {18},
number = {7},
doi = {10.1093/ckj/sfaf161}
}
EUVIMED